Deepak S. Nath, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 189 shares at $41.31 ($8K) on 2016-04-28, disclosed to the SEC on 2016-04-29.
Scheduled sale ($8k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.31 | 53 | $2K | 26.9% |
| 2 | $43.83 | 136 | $6K | 73.1% |
| Total | $43.12 avg | 189 | $8K | 100% |
| Filing → |
| ABT | SELL | 2016-03-02 | $31K | — | Filing → |
| ABT | SELL | 2016-02-23 | $12K | — | Filing → |
| ABT | SELL | 2016-02-17 | $6K | — | Filing → |